FDMT vs IR · rev $37.0K vs P/E 49, rev $7.24B
4D Molecular Therapeutics Inc (FDMT) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
FDMT currently screens at market cap $518.1M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the FDMT and IR stock pages for the full models.
Not investment advice.